Back to search resultsSummaryRMgm-4658
|
||||||||
*RMgm-4658| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene tagging |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 31370870 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Yeoh LM, McFadden GI, Ralph SA |
| Name Group/Department | Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institut |
| Name Institute | The University of Melbourne |
| City | Parkville |
| Country | Australia |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-4658 |
| Principal name | PbSR-MG HA-tagged |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | Localizing an integrated, hemagglutinin-tagged (HA-tagged) PbSR-MG confirmed its expected nuclear localization |
| Gametocyte/Gamete | Localizing an integrated, hemagglutinin-tagged (HA-tagged) PbSR-MG confirmed its expected nuclear localization |
| Fertilization and ookinete | Not tested |
| Oocyst | Not tested |
| Sporozoite | Not tested |
| Liver stage | Not tested |
| Additional remarks phenotype | Mutant/mutation Localizing an integrated, hemagglutinin-tagged (HA-tagged) PbSR-MG confirmed its expected nuclear localization Phenotype Phenotype analyses of a mutant lacking expression of PbSR-MG showed the follwing (see mutant RMgm-4657):
|
Tagged: Mutant parasite with a tagged gene| top of page | |||||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_0921600 | ||||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_1126800 | ||||||||||||||||||||||||||
| Gene product | RNA-binding protein, putative | ||||||||||||||||||||||||||
| Gene product: Alternative name | PbSR-MG | ||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||||
| Name of the tag | triple-HA | ||||||||||||||||||||||||||
| Details of tagging | C-terminal | ||||||||||||||||||||||||||
| Additional remarks: tagging | |||||||||||||||||||||||||||
| Commercial source of tag-antibodies | |||||||||||||||||||||||||||
| Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||||
| Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||||
| Additional remarks genetic modification | The hemagglutinin epitope-tagged line was created by modification of a pL0006-based plasmid. This plasmid was designed for single-site recombination into P. berghei and includes three hemagglutinin (HA) tags, followed by the 3'-UTR of KAHRP, followed by a DHFR selectable marker. We cloned the 3' end of PbSR-MG from genomic DNA with the primers “PbSR-MG 3'-HindIIIApaI SP” and “PbSR-MG 3_-AvrII-BglII ASP” and ligated this into the vector backbone. | ||||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||